ArticleJournal for immunotherapy of cancer2013

A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.

Daniel M Geynisman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.